T-20--a fusion drug, first of several to come.
D019380:Anti-HIV Agents / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D015507:Drugs, Investigational; D015700:HIV Envelope Protein gp41 / Q000494:pharmacology*; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D015497:HIV-1 / Q000187:drug effects / Q000502:physiology; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D010446:Peptide Fragments / Q000494:pharmacology; D019562:Viral Load; D014779:Virus Replication / Q000187:drug effects*
D019380:Anti-HIV Agents; D015507:Drugs, Investigational; D015700:HIV Envelope Protein gp41; D010446:Peptide Fragments